We are live on !
Find out more
TIAA CREF Trust Portfolio holdings
AUM
$13.8B
Turnover
11.97%
1-Year Est. Return
10.67%
This Fund
S&P 500
This Quarter Est. Return
+3.79%
1 Year Est. Return
+10.67%
3 Year Est. Return
+14.85%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$13.8B
AUM Growth
+$1.15B
(+9.1%)
Cap. Flow
+$691M
Cap. Flow % of AUM
Cap. Flow %
4.99%
Top 10 Holdings %
Top 10 Hldgs %
55.43%
Holding
376
New
26
Increased
159
Reduced
161
Closed
19
Avg Time Held
2.7
years
Top 10 Avg Time Held
3.1
years
Top 20 Avg Time Held
3.1
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Short-Term Bond ETF
BSV
|
+$111M |
| 2 |
iShares Russell 1000 Value ETF
IWD
|
+$108M |
| 3 |
iShares Russell 1000 Growth ETF
IWF
|
+$86.9M |
| 4 |
iShares Russell Mid-Cap Value ETF
IWS
|
+$62.2M |
| 5 |
State Street SPDR Dow Jones REIT ETF
RWR
|
+$50.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alerian MLP ETF
AMLP
|
+$36.6M |
| 2 |
iShares TIPS Bond ETF
TIP
|
+$17.6M |
| 3 |
Apple
AAPL
|
+$7.44M |
| 4 |
Boeing
BA
|
+$5.59M |
| 5 |
American International
AIG
|
+$5.55M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 87.46% |
| 2 | Healthcare | 2.14% |
| 3 | Financials | 2.01% |
| 4 | Technology | 1.72% |
| 5 | Industrials | 1.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
51
Vanguard Morningstar Small-Cap Growth ETF
VBK
$22.2B
| $28.6M | 0.21% |
203,496
-569
| -0.3% | -$78.8K |
2013 Q2
15 quarters
|
|
52
Lowe's Companies
LOW
$110B
| $24.5M | 0.18% |
298,104
-2,627
| -0.9% | -$201K |
2013 Q2
15 quarters
|
|
53
iShares Core S&P Small-Cap ETF
IJR
$102B
| $24.3M | 0.18% |
350,966
+22,138
| +7% | +$1.53M |
2013 Q2
15 quarters
|
|
54
Adobe
ADBE
$96.2B
| $23.4M | 0.17% |
179,631
-15,261
| -8% | -$1.79M |
2013 Q2
15 quarters
|
|
55
3M
MMM
$83.6B
| $23M | 0.17% |
143,986
-5,239
| -4% | -$804K |
2013 Q2
15 quarters
|
|
56
UnitedHealth
UNH
$365B
| $21.8M | 0.16% |
132,907
+1,724
| +1% | +$282K |
2013 Q2
15 quarters
|
|
57
Microsoft
MSFT
$3.96T
| $21.5M | 0.16% |
326,122
+55,379
| +20% | +$3.55M |
2013 Q2
15 quarters
|
|
58
Procter & Gamble
PG
$366B
| $21.1M | 0.15% |
234,637
+1,575
| +0.7% | +$140K |
2013 Q2
15 quarters
|
|
59
Oracle
ORCL
$393B
| $20.9M | 0.15% |
469,070
-52,214
| -10% | -$2.17M |
2013 Q2
15 quarters
|
|
60
Vanguard Morningstar Total Stock Market ETF
VTI
$692B
| $20.4M | 0.15% |
167,920
+1,286
| +0.8% | +$154K |
2013 Q2
15 quarters
|
|
61
Thermo Fisher Scientific
TMO
$251B
| $20M | 0.14% |
130,535
+953
| +0.7% | +$146K |
2013 Q2
15 quarters
|
|
62
Amgen
AMGN
$230B
| $19.1M | 0.14% |
116,558
-13,233
| -10% | -$2.2M |
2013 Q2
15 quarters
|
|
63
Merck
MRK
$354B
| $18.5M | 0.13% |
305,591
-8,434
| -3% | -$512K |
2013 Q2
15 quarters
|
|
64
Visa
V
$756B
| $18.2M | 0.13% |
204,236
+760
| +0.4% | +$65.4K |
2015 Q1
8 quarters
|
|
65
Chevron
CVX
$440B
| $18M | 0.13% |
168,080
+1,370
| +0.8% | +$154K |
2013 Q2
15 quarters
|
|
66
Travelers Companies
TRV
$80.4B
| $18M | 0.13% |
149,005
+17,971
| +14% | +$2.16M |
2013 Q2
15 quarters
|
|
67
Amazon
AMZN
$2.83T
| $17.5M | 0.13% |
395,200
+71,840
| +22% | +$2.99M |
2016 Q2
3 quarters
|
|
68
Vanguard Morningstar Large-Cap ETF
VV
$54.4B
| $17.1M | 0.12% |
158,540
-3,703
| -2% | -$395K |
2013 Q2
15 quarters
|
|
69
Honeywell
HON
$66.6B
| $16.6M | 0.12% |
146,958
+3,702
| +3% | +$409K |
2013 Q2
15 quarters
|
|
|
70
American International
AIG
$42.2B
| $16.3M | 0.12% |
260,964
-86,453
| -25% | -$5.55M |
2013 Q2
15 quarters
|
|
|
CELG
71
DELISTED
Celgene Corp
CELG
| $16.2M | 0.12% |
130,215
-626
| -0.5% | -$74.9K |
2014 Q2
11 quarters
|
|
72
IBM
IBM
$223B
| $16M | 0.12% |
96,183
-396
| -0.4% | -$66.4K |
2013 Q2
15 quarters
|
|
73
Vanguard Total Bond Market
BND
$163B
| $15.9M | 0.11% |
195,759
+9,119
| +5% | +$737K |
2013 Q2
15 quarters
|
|
74
RTX Corp
RTX
$259B
| $15.8M | 0.11% |
223,050
-16,133
| -7% | -$1.13M |
2013 Q2
15 quarters
|
|
75
Capital One
COF
$123B
| $15.7M | 0.11% |
181,299
-8,019
| -4% | -$714K |
2013 Q2
15 quarters
|
|
Similar funds
EPCM
LT
TIAA CREF Trust's Q1 2017 Portfolio in Review
As of Q1 2017, TIAA CREF Trust held 376 positions worth $13.8B, up 9.1% from $12.7B the previous quarter. Its ten largest holdings account for 55% of the portfolio.
TIAA CREF Trust deployed $691M of net new capital in Q1 2017, opening 26 new positions and adding to 159 existing holdings. Its largest new stake was Allergan plc: 35,527 shares worth $8.49M.
By sector, the portfolio is most concentrated in Miscellaneous at 87% of assets, up from 87% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Alerian MLP ETF, an estimated $36.6M trimmed.
- TIAA CREF Trust's largest Q1 2017 buy was Allergan plc: 35,527 shares worth $8.49M.
- TIAA CREF Trust added most to Vanguard Short-Term Bond ETF in Q1 2017, an estimated $111M increase.
- TIAA CREF Trust's biggest Q1 2017 reduction was Alerian MLP ETF, cutting an estimated $36.6M.
- TIAA CREF Trust fully exited Biogen in Q1 2017, selling an estimated $3.15M.
- TIAA CREF Trust's ten largest holdings make up 55% of its $13.8B portfolio in Q1 2017.
- TIAA CREF Trust opened 26 new positions and closed 19 in Q1 2017.
- TIAA CREF Trust's portfolio value rose 9.1% quarter-over-quarter to $13.8B.
Based on TIAA CREF Trust's 13F filing for Q1 2017, filed 3 May 2017.